Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic therapy with ME2906 and PNL6405CNS in malignant brain tumors
jRCT1091220026Completed
- Sponsor
- Institute of Advanced Biomedical Engineering, Tokyo Women's Medical University
- Start
- Mar 2009
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of talaporfin sodium in brain neoplasm, sponsored by Institute of Advanced Biomedical Engineering, Tokyo Women's Medical University. Primary endpoint: Overall survival. Started Mar 2009; status: completed.
02
Drugs
talaporfin sodium
03
Conditions
brain neoplasm
Beyond the preview
Go deeper on jRCT1091220026.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220026.